Artículo
DNA mismatch repair activity of MutLα is regulated by CK2-dependent phosphorylation of MLH1 (S477)
Weßbecher, Isabel M.; Hinrichsen, Inga; Funke, Sebastian; Oellerich, Thomas; Plotz, Guido; Zeuzem, Stefan; Grus, Franz H.; Biondi, Ricardo Miguel
; Brieger, Angela
Fecha de publicación:
12/2018
Editorial:
Wiley-liss, Div John Wiley & Sons Inc
Revista:
Molecular Carcinogenesis
ISSN:
0899-1987
Idioma:
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
MutLα, a heterodimer consisting of MLH1 and PMS2, is a key player of DNA mismatch repair (MMR), yet little is known about its regulation. In this study, we used mass spectrometry to identify phosphorylated residues within MLH1 and PMS2. The most frequently detected phosphorylated amino acid was serine 477 of MLH1. Pharmacological treatment indicates that Casein kinase II (CK2) could be responsible for the phosphorylation of MLH1 at serine 477 in vivo. In vitro kinase assay verified MLH1 as a substrate of CK2. Most importantly, using in vitro MMR assay we could demonstrate that p-MLH1S477 lost MMR activity. Moreover, we found that levels of p-MLH1S477 varied during the cell cycle. In summary, we identified that phosphorylation of MLH1 by CK2 at amino acid position 477 can switch off MMR activity in vitro. Since CK2 is overexpressed in many tumors and is able to inactivate MMR, the new mechanism here described could have an important impact on tumors overactive in CK2.
Palabras clave:
CK2
,
DNA MISMATCH REPAIR
,
LYNCH SYNDROME
,
MLH1
,
MUTLΑ
,
PHOSPHORYLATION
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(IBIOBA - MPSP)
Articulos de INST. D/INV.EN BIOMED.DE BS AS-CONICET-INST. PARTNER SOCIEDAD MAX PLANCK
Articulos de INST. D/INV.EN BIOMED.DE BS AS-CONICET-INST. PARTNER SOCIEDAD MAX PLANCK
Citación
Weßbecher, Isabel M.; Hinrichsen, Inga; Funke, Sebastian; Oellerich, Thomas; Plotz, Guido; et al.; DNA mismatch repair activity of MutLα is regulated by CK2-dependent phosphorylation of MLH1 (S477); Wiley-liss, Div John Wiley & Sons Inc; Molecular Carcinogenesis; 57; 12; 12-2018; 1723-1734
Compartir
Altmétricas